癌の生態系におけるゲノムとエピゲノム進化のマッピング
Toshikazu Ushijima1, Susan J Clark2,3, Patrick Tan4,5,6,7
1Division of Epigenomics, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
まとめ
マルチモダルのデータを統合することは,がんを理解する上で極めて重要です.
科学分野:
- 腫瘍学
- ゲノミクス
- エピジェノミクス
背景:
- 死因の1つである癌は ゲノムとエピジェノムの変化から生じます
- 一見正常な組織における 初期の分子変化は 伝統的な癌の発症の定義に 異議を唱えるものです
- 後期段階には,クローン選択,表遺伝子学的適応,転移性および治療抵抗性の持続細胞が含まれます.
研究 の 目的:
- 癌研究における多式データ統合の重要性を強調する.
- 癌の分子進化を 研究する
- 癌の開発と治療における新たな研究分野を強調する.
主な方法:
- マルチモダルのデータの統合
- ゲノムとエピゲノムの変化の分析
- 単細胞と空間技術の応用
主要な成果:
- ドライバ変異と表遺伝子変異は正常な組織に存在します.
- クローン選択,エピジェノミック適応,持続細胞は転移と治療抵抗に影響する.
- 腫瘍の生態系は 癌の発生に重要な役割を果たし 先進技術によって明らかにされています
結論:
- 癌の分子進化を理解するには 多様データ統合が不可欠です
- 癌のライフサイクル全体にわたる 総合的な腫瘍アトラスの開発は不可欠です
- このアプローチにより 癌のリスクの評価が改善され 治療法の発見が加速されます
さらに関連する動画
09:01Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
Published on: July 3, 2025
463
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
1.8K
関連する概念動画
Epigenetic Regulation
3.2K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.2K
Cancers Originate from Somatic Mutations in a Single Cell
13.3K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.3K
Evolutionary Relationships through Genome Comparisons
6.5K
Genome comparison is one of the excellent ways to interpret the evolutionary relationships between organisms. The basic principle of genome comparison is that if two species share a common feature, it is likely encoded by the DNA sequence conserved between both species. The advent of genome sequencing technologies in the late 20th century enabled scientists to understand the concept of conservation of domains between species and helped them to deduce evolutionary relationships across diverse...
6.5K
Genomics
38.0K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
38.0K
Tumor Progression
6.6K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.6K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
